Warfarin: is the end nigh? Please?
Department of Haematology, Forth Valley Royal Hospital, Larbert, Stirlingshire, UK. roderick.neilson@nhs.net
R F
RF
Neilson
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications*; D001562:Benzimidazoles / Q000627:therapeutic use*; D000069604:Dabigatran; D004617:Embolism / Q000209:etiology* / Q000517:prevention & control*; D006801:Humans; D011725:Pyridines / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D020521:Stroke / Q000209:etiology* / Q000517:prevention & control*; D016896:Treatment Outcome; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use*
D000925:Anticoagulants; D001562:Benzimidazoles; D011725:Pyridines; D014859:Warfarin; D000069604:Dabigatran